StemCell Institute
StemCell Institute Inc. specializes in the banking of stem cells, focusing on the storage and processing of cord blood for regenerative medicine. Founded in 1999 and headquartered in Tokyo, Japan, the company operates additional offices in major cities including Shizuoka, Nagoya, Osaka, Okayama, and Fukuoka. Its services involve collecting umbilical cord blood from obstetric facilities across Japan and transporting it to its processing center within 48 hours. Once there, the blood is separated into its constituent cells and stored at ultra-low temperatures to ensure viability for future medical treatments. The institute also engages in research and development of innovative stem cell therapies, supporting families in need of regenerative medicine and cell therapy with autologous cord blood cells. As of 2015, StemCell Institute operates as a subsidiary of Trim Medical Holdings Inc.
Cuorips Inc. is a Japanese company focused on the research, development, and commercialization of induced pluripotent stem (iPS) cell-derived cardiomyocyte sheets and cell therapeutic products. Founded in 2017, Cuorips, formerly known as Cuore Inc., operates from its headquarters in Chuo, Japan, with an additional office in Osaka. The company aims to advance medical care by leveraging cutting-edge technology to create innovative solutions in the field of regenerative medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.